A Recurring Nightmare: Tainted Blood Products in China

A Recurring Nightmare: Tainted Blood Products in China
Hemophiliac protesters, all of whom contracted HIV from infected blood products, wear surgical masks as they demonstrate during an AIDS-awareness event on World AIDS Day at Beijing's south railway station on Dec. 1, 2009, to call for better government support for HIV/AIDS victims in China. AFP/Getty Images
|Updated:

News Analysis

China’s National Health Commission issued on Feb. 5 an order to recall a batch of human immunoglobulin for intravenous injection, for possibly being contaminated with HIV (tested Positive for anti-HIV antibodies). One baby in Jiangxi Province injected with this batch of human immunoglobulin was also tested positive for HIV antibodies. The Shanghai Medical Products Administration identified that the contaminated batch was identified as number 20180610Z, which was made by China Meheco Xinxing Pharma Co. This suspected batch consisted of 12,226 units, due to expire in 2021.

This quickly triggered another wave of public outrages for the concerns of medical product safety in China, as scandals about contaminated rabies vaccine and using expired polio vaccine products for infants were exposed in the last few months in China.

Xiaoxu Sean Lin
Xiaoxu Sean Lin
Ph.D.
Xiaoxu Sean Lin is an assistant professor in the Biomedical Science Department at Feitian College in Middletown, New York. He is also a frequent analyst and commentator for Epoch Media Group, VOA, and RFA. He is a veteran who served as a U.S. Army microbiologist and also a member of Committee on the Present Danger: China.
twitter
Related Topics